Mechanisms of Prooxidants in NeuroInflammatory Processes and Clinical Manifestations

References (65)

1. 1 Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. [DOI]
2. 2 Parkinson's Disease [DOI]
3. 3 Oxygen toxicity, oxygen radicals, transition metals and disease [DOI]
4. 4 Glutathione Metabolism and Its Implications for Health [DOI]
5. 5 Oxidative Stress, Glutamate, and Neurodegenerative Disorders [DOI]
6. 6 Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease [DOI]
7. 7 Mechanisms of Hepatotoxicity [DOI]
8. 8 Metals, oxidative stress and neurodegenerative disorders [DOI]
9. 9 Oxidative damage in multiple sclerosis lesions [DOI]
10. 10 In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression [DOI]
11. 11 Altered Lipid Metabolism in Brain Injury and Disorders [DOI]
12. 12 Hydrogen Peroxide Poisoning [DOI]
13. 13 Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent [DOI]
14. 14 Age-related changes in reactive oxygen species production in rat brain homogenates [DOI]
15. 15 Impact of the Discovery of Human Zinc Deficiency on Health [DOI]
16. 16 Aging‐dependent changes of microglial cells and their relevance for neurodegenerative disorders [DOI]
17. 17 Deletion of the Prostaglandin E2EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease [DOI]
18. 18 The role of inflammasome in Alzheimer's disease [DOI]
19. 19 Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms [DOI]
20. 20 The Prostaglandin E2 E-Prostanoid 4 Receptor Exerts Anti-Inflammatory Effects in Brain Innate Immunity [DOI]
21. 21 The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons [DOI]
22. 22 Myeloperoxidase-Derived Oxidants Induce Blood-Brain Barrier Dysfunction In Vitro and In Vivo [DOI]
23. 23 Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease [DOI]
24. 24 Evaluation of the antioxidative properties of lipoxygenase inhibitors [DOI]
25. 25 Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain [DOI]
26. 26 Tryptophan metabolism and oxidative stress in patients with chronic brain injury [DOI]
27. 27 Fisetin Enhances Behavioral Performances and Attenuates Reactive Gliosis and Inflammation During Aluminum Chloride-Induced Neurotoxicity [DOI]
28. 28 Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease [DOI]
29. 29 Hydrogen peroxide is a novel mediator of inflammatory hyperalgesia, acting via transient receptor potential vanilloid 1-dependent and independent mechanisms [DOI]
30. 30 Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage [DOI]
31. 31 Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats [DOI]
32. 32 Dimemorfan protects rats against ischemic stroke through activation of sigma‐1 receptor‐mediated mechanisms by decreasing glutamate accumulation [DOI]
33. 33 Antioxidants, trace elements and metabolic syndrome in elderly subjects [DOI]
34. 34 Inhibition of cellular antioxidants: a possible mechanism of toxic cell injury. [DOI]
35. 35 Neuro‐ and Cardioprotective Effects of Blockade of Nitric Oxide Action by Administration of Methylene Blue [DOI]
36. 36 High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: Implications for atherosclerosis [DOI]
37. 37 Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats [DOI]
38. 38 Zileuton Reduces Inflammatory Reaction and Brain Damage Following Permanent Cerebral Ischemia in Rats [DOI]
39. 39 Anti-inflammatory effect of melatonin on Aβ vaccination in mice [DOI]
40. 40 Central neurological complications in critically ill patients with malignancies [DOI]
41. 41 Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats [DOI]
42. 42 Oxygen Toxicity Is Reduced by Acetylcholinesterase Inhibition in the Developing Rat Brain [DOI]
43. 43 Effect of a specific iron chelating agent on animal models of inflammation. [DOI]
44. 44 Protective effects of l-pGlu-(2-propyl)-l-His-l-ProNH2, a newer thyrotropin releasing hormone analog in in vitro and in vivo models of cerebral ischemia [DOI]
45. 45 Neuronal degeneration and iNOS expression in experimental brain contusion following treatment with colchicine, dexamethasone, tirilazad mesylate and nimodipine [DOI]
46. 46 Effects of trace element supplementation on the inflammatory response in a rabbit model of major trauma [DOI]
47. 47 Predictors of Deteriorating Cerebral Infarct: Role of Inflammatory Mechanisms. Would Its Early Treatment Be Useful? [DOI]
48. 48 Inhibitory effects of short-term administration of dl-α-lipoic acid on oxidative vulnerability induced by Aβ amyloid fibrils (25–35) in mice [DOI]
49. 49 Hyperthermia amplifies brain cytokine and reactive oxygen species response in a model of perinatal inflammation [DOI]
50. 50 Handbook of free radicals : formation, types and effects
51. 51 Free radicals and antioxidants in normal physiological functions and human disease [DOI]
52. 52 ACETAMINOPHEN-INDUCED HEPATOTOXICITY [DOI]
53. 53 Oxidative Stress, Antioxidants, and Animal Function [DOI]
54. 54 Tryptophan metabolism and oxidative stress in patients with Huntington's disease [DOI]
55. 55 Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease [DOI]
56. 56 Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress [DOI]
57. 57 Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage [DOI]
58. 58 Linkage of Some Trace Elements, Peripheral Blood Lymphocytes, Inflammation, and Oxidative Stress in Patients Undergoing Either Hemodialysis or Peritoneal Dialysis [DOI]
59. 59 Antioxidant Micronutrients and Biomarkers of Oxidative Stress and Inflammation in Colorectal Adenoma Patients: Results from a Randomized, Controlled Clinical Trial [DOI]
60. 60 Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits [DOI]
61. 61 Protective effect of non-selective and selective COX-2-inhibitors in acute immobilization stress-induced behavioral and biochemical alterations.
62. 62 Prooxidant effects of antioxidant vitamins. Introduction.
63. 63 Inhibition of Cellular Antioxidants: A Possible Mechanism of Toxic Cell Injury [DOI]
64. 64 Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases [DOI]
65. 65 [Anemia during inflammatory processes: pathogenesis and clinical and morphological manifestations].

Cited by 4

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

• Serum Lead and Micronutrients Levels in Public Transport Drivers in Osogbo, Nigeria — shares topic coverage
• Effect of Shrimp Shell Flour Substitution on Croissant Liking Level — shares topic coverage
• Evaluation of the Level of Aflatoxins in Raw Peanuts and Reduction Levels of Aflatoxins in Peanuts through Nixtamalization (Lime Treatment) and Calcium Enrichment — shares topic coverage
• Process Optimization for Calcium- and Fiber-rich Kale Powder Using Response Surface Methodology — shares topic coverage
• Comparison of the Effect of Vit E, VitB6, Calcium and Omega-3 on the Treatment of Premenstrual Syndrome: A Clinical Randomized Trial — shares topic coverage